第二届医疗器械研发论坛回顾：从研发源头看产业创新动能

Core Insights - The second Medical Device R&D Forum was successfully held at the Medtec 2025 International Medical Device Design and Manufacturing Technology Exhibition, highlighting the growth and internationalization of China's medical device industry [2][4] - The forum emphasized the importance of collaboration between hospitals and the industry to drive innovation and technology transfer [8][34] Group 1: Forum Highlights - Zhao Qing, founder of SiYu MedTech, stated that Medtec focuses on the "source" of medical devices, serving as a platform for industry exchange and innovation acceleration [2] - Gu Xiaoyuan, General Manager of Informa Group's Medical Health & IP Licensing, noted that Medtec China has been a key player in the medical device industry for over 20 years, facilitating industry communication and international cooperation [4] Group 2: Innovation and Technology Transfer - Lei Juan, Director of the Sichuan West Medical Technology Transfer Center, shared experiences in transforming scientific achievements into products, emphasizing the role of hospitals as sources of technology transfer [8] - Cao Gangyi, CEO of Huanxin Medical, discussed the complexities of cardiovascular interventional devices and the importance of clinical needs in product design and patent strategy [10] - Wang Kai from Nankai University presented advancements in vascular injury repair and regeneration materials, showcasing their potential applications in vascular reconstruction [12] Group 3: Industry Collaboration and New Materials - Wang Hanxuan, a scientist from Switzerland, analyzed how large companies like Novartis create value through innovation and the role of international technology clusters in promoting R&D and industry cycles [14] - Shi Chen, CEO of InnoCo, shared the development journey of Chro-Mg™ controlled degradation magnesium alloy, which offers new possibilities for orthopedic devices [16] Group 4: Supply Chain and Compliance - Zhao Qing provided an overview of the medical device supply chain and emphasized its vulnerabilities, urging upstream companies to collaborate with manufacturers for innovative product development [18] - Shi Daifeng, Technical Director at China Inspection and Testing International, highlighted the importance of considering testing points early in the R&D process to avoid registration delays [20] Group 5: Emerging Trends and AI Integration - Zhou Gui, General Manager of Beijing Lila Technology, discussed the application of PDRN in implantable agents within the aesthetic medicine sector, indicating the potential for cross-industry material expansion [22] - Han Chen, Co-founder of Beijing Haisheng Medical Devices, presented the research and clinical exploration of fully degradable stents for diabetic patients, aiming to attract attention from hospitals and investors [24] - Zhang Bowei, CTO of Vascular Cube Medical Device Incubator, explored new models for medical device innovation incubation, particularly in peripheral vascular and cardiac pacing fields [26] Group 6: Future Outlook - The forum brought together experts from hospitals, research institutions, innovative companies, testing agencies, and incubation platforms to discuss materials, patents, standards, clinical applications, and international experiences [34] - The discussions reflected the transition of China's medical device industry from "following" to "running alongside and leading," with SiYu MedTech committed to fostering industry communication and documenting innovation growth [34]